Sign up to save your podcasts
Or
Share DAPT Dilemmas Endure While BMS Should Fade Away
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
DAPT Dilemmas Endure While BMS Should Fade Away
Dual antiplatelet therapy duration after coronary stenting remains debatable. Drs Harrington, Batchelor, and O'Donoghue discuss some of the data from TCT and predict the demise of bare metal stents.
View all episodes
By MedscapeDual antiplatelet therapy duration after coronary stenting remains debatable. Drs Harrington, Batchelor, and O'Donoghue discuss some of the data from TCT and predict the demise of bare metal stents.